Late recurrence of an embryonal carcinoma of the testis. Case report
Abstract
Keywords
Full Text:
PDFReferences
Casciato DA, Territo MC. Manual of Clinical Oncology, 7th Edition. Philadelphia: Lippincott Williams & Wilkins, 2012.
Hussain SA, Ma YT, Cullen MH. Management of metastatic germ cell tumors. Expert Rev Anticancer Ther 2008; 8(5):771–784.
Albers P. Diagnosis, staging, and risk factors: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology 2011; 78:S427-434.
Nakamura T, Miki T. Recent strategy for the management of advanced testicular cancer. Int J Urol 2010; 17(2):148-157.
Motzer RJ, Agarwal N, Beard C, et al. Testicular cancer. J Natl Compr Canc Netw 2009; 7(6):672-693.
Kollmannsberger C, Honecker F, Bokemeyer C. Pharmacotherapy of relapsed metastatic testicular cancer. Expert Opin Pharmacother 2008; 9(13):2259-2272.
Khurana K, Gilligan TD, Stephenson AJ. Management of poor-prognosis testicular germ cell tumors. Indian J Urol 2010; 26(1):108-114.
Herdrich K, Weinberger H. Selected schedules in the therapy of malignant tumors, 17th Edition. Deerfield: Baxter International Inc, 2013.
Beyer, S. Stenning, A. Gerl, et al. High-dose versus conventional-dose chemotherapy as first salvage therapy in patients with non-seminomatous germ-cell tumours: a matched pair analysis. Ann Oncol 2002; 13:599-605.
NCCN Clinical Practice Guidelines in Oncology. Testicular cancer, v2.2015 [http://www.nccn.org/professionals/physician_gls/pdf/testicular.pdf available at 05/13/2015].
Oldenburg, Fosså SD, J. Nuver J, et al. Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines. Ann Oncol 2013; 24(suppl 6):vi125-vi132.
Nastały P, Ruf C, Becker P, et al. Circulating tumor cells in patients with testicular germ cell tumors. Clin Cancer Res 2014; 20(14):3830-3841.
Fizazi K, Oldenburg J, Dunant A, et al. Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results from the sCR2 international study. Ann Oncol 2008; 19(2):259-264.
Kondagunta GV, Bacik J, Donadio A, et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 2005; 23(27):6449-6555.
International Prognostic Factors Study Group, Lorch A, Beyer J, et al. Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J Clin Oncol 2010; 28(33):4906-4911.
Oldenburg J, Wahlqvist R, Fosså SD. Late relapse of germ cell tumors. World J Urol 2009; 27(4):493-500.
DOI: http://dx.doi.org/10.22551/2015.06.0202.10033
Copyright (c) 2015 Archive of Clinical Cases
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ISSN: 2360-6975